Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial

Holly R. Keir, Merete B. Long, Hani Abo-leyah, Yan Hui Giam, Thenmalar Vadiveloo, Thomas Pembridge, Rebecca C. Hull, Lilia Delgado, Margaret Band, Fiona McLaren-Neil, Simon Adamson, Eva Lahnsteiner, Amy Gilmour, Chloe Hughes, Benjamin JM New, David Connell, Rebecca Dowey, Helena Turton, Hollian Richardson, Diane CassidyJamie Cooper, Jay Suntharalingam, Lavanya Diwakar, Peter Russell, Jonathan Underwood, Alexander Hicks, Davinder P. S. Dosanjh, Beth Sage, Devesh Dhasmana, Mark Spears, A. A. Roger Thompson, Christopher Brightling, Andrew Smith, Manish Patel, Jacob George, Alison M. Condliffe, Amelia Shoemark, Graeme MacLennan, James D. Chalmers (Lead / Corresponding author), STOP-COVID19 Investigators

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)
11 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences